Atika Capital Management LLC Neurocrine Biosciences Inc Transaction History
Atika Capital Management LLC
- $841 Million
- Q2 2024
A detailed history of Atika Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Atika Capital Management LLC holds 44,500 shares of NBIX stock, worth $5.12 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
44,500
Previous 58,000
23.28%
Holding current value
$5.12 Million
Previous $8 Million
23.42%
% of portfolio
0.73%
Previous 0.92%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$530 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$284 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$272 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...